Berkeley Energia Limited (ASX:BKY)

CTI BioPharma Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 12, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	232	152	283	158	145	116
Market Cap Growth	14.54%	-46.46%	78.87%	9.12%	24.63%	28.64%
Enterprise Value	152	76	204	80	155	64
Last Close Price	0.52	0.34	0.64	0.35	0.56	0.45
PE Ratio	224.33	-	-	2.43	-	-
PB Ratio	2.68	1.79	3.24	1.81	-10.88	3.21
P/TBV Ratio	2.68	1.79	3.24	1.81	-	3.21
Debt / Equity Ratio	-	-	-	-	-7.24	2.09
Quick Ratio	48.32	31.39	39.03	35.87	0.78	1.18
Current Ratio	48.32	31.39	39.03	35.87	0.78	1.18
Return on Equity (ROE)	1.20%	-3.79%	-1.57%	175.07%	-429.39%	-74.04%
Return on Assets (ROA)	-4.45%	-4.29%	-3.78%	-3.49%	-9.16%	-4.25%
Return on Capital (ROIC)	-4.57%	-4.41%	-3.87%	-3.68%	-9.63%	-4.38%
Earnings Yield	0.44%	-2.15%	-0.48%	41.10%	-33.87%	-36.85%
FCF Yield	-	-0.99%	-1.46%	-3.66%	-3.92%	-6.37%
Buyback Yield / Dilution	1.36%	-	-	-0.06%	-72.31%	28.04%

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.